Ngā hua rapu - Quentin M. Anstee

Whakamahine hua
  1. 1
    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research mā Quentin M. Anstee, Robert Goldin

    I whakaputaina 2006
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 mā Christopher P. Day, Quentin M. Anstee

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility

    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility mā Quentin M. Anstee, Christopher P. Day

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment mā Paola Dongiovanni, Quentin M. Anstee, Luca Valenti

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis

    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis mā Mazen Noureddin, Quentin M. Anstee, Rohit Loomba

    I whakaputaina 2016
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease

    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease mā Marie Boyle, Steven Masson, Quentin M. Anstee

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Impact of non-invasive biomarkers on hepatology practice: Past, present and future

    Impact of non-invasive biomarkers on hepatology practice: Past, present and future mā Quentin M. Anstee, Laurent Castéra, Rohit Loomba

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Nonalcoholic fatty liver disease

    Nonalcoholic fatty liver disease mā Timothy Hardy, Quentin M. Anstee, Christopher P. Day

    I whakaputaina 2015
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Non-alcoholic fatty liver disease: a practical approach to treatment

    Non-alcoholic fatty liver disease: a practical approach to treatment mā Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    I whakaputaina 2014
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging mā Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    NAFLD-Associated HCC: Progress and Opportunities

    NAFLD-Associated HCC: Progress and Opportunities mā Daniel Geh, Quentin M. Anstee, Helen L. Reeves

    I whakaputaina 2021
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    Genetic modifiers of non-alcoholic fatty liver disease progression

    Genetic modifiers of non-alcoholic fatty liver disease progression mā Quentin M. Anstee, Ann K. Daly, Christopher P. Day

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    How big a problem is non-alcoholic fatty liver disease?

    How big a problem is non-alcoholic fatty liver disease? mā Quentin M. Anstee, Stuart McPherson, C.P. Day

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases mā Leon A. Adams, Quentin M. Anstee, Herbert Tilg, Giovanni Targher

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    The Global Burden of Liver Disease

    The Global Burden of Liver Disease mā Zobair M. Younossi, Grace Lai‐Hung Wong, Quentin M. Anstee, Linda Henry

    I whakaputaina 2023
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Thrombin and factor Xa link the coagulation system with liver fibrosis

    Thrombin and factor Xa link the coagulation system with liver fibrosis mā Ameet Dhar, Fouzia Sadiq, Quentin M. Anstee, Adam Levene, Robert Goldin, Mark Thursz

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study

    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease... mā Kate Hallsworth, Stephan U Dombrowski, Stuart McPherson, Quentin M. Anstee, Leah Avery

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease mā Stuart McPherson, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis

    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis mā Helen Jarvis, Hannah O’Keefe, Dawn Craig, Daniel Stow, Barbara Hanratty, Quentin M. Anstee

    I whakaputaina 2022
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice

    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice mā Leah Avery, Catherine Exley, Stuart McPherson, Michael I. Trenell, Quentin M. Anstee, Kate Hallsworth

    I whakaputaina 2017
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: